These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Beta-blockers in the prevention of gastrointestinal bleeding. Lebrec L Rev Invest Clin; 1990 Jul; 42 Suppl():159-64. PubMed ID: 19256157 [TBL] [Abstract][Full Text] [Related]
24. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns. Rywik TM; Rywik SL; Korewicki J; Broda G; Sarnecka A; Drewla J Int J Cardiol; 2004 Jun; 95(2-3):177-84. PubMed ID: 15193817 [TBL] [Abstract][Full Text] [Related]
25. Beta-adrenergic blockers for portal hypertension. Lessons from animal models. Sikuler E J Hepatol; 1991 Mar; 12(2):133-5. PubMed ID: 1675643 [No Abstract] [Full Text] [Related]
26. Beta-blockers in portal hypertension. An overview. Lewis JA; Davis JM; Allsopp D; Cameron HA Drugs; 1989; 37 Suppl 2():62-9; discussion 74-6. PubMed ID: 2572413 [TBL] [Abstract][Full Text] [Related]
27. [Has the time come to measure the hemodynamic response to pharmaco-logical treatments of portal hypertension?]. Morales J; Péron JM; Vinel JP Gastroenterol Clin Biol; 2001 Oct; 25(10):863-5. PubMed ID: 11852386 [No Abstract] [Full Text] [Related]
28. [Correction of portal hypertension by beta-adrenoblockers (atenolol and metoprolol) and inhibitors of ACE (lisinopril and enalapril) in liver cirrhosis]. Lazebnik LB; Mikheeva OM; Toporkov AS; Komissarenko IA; Vasnev OS; Fedulenkova LV Eksp Klin Gastroenterol; 2007; (5):57-66. PubMed ID: 18389599 [No Abstract] [Full Text] [Related]
29. [Drug therapy of portal hypertension]. Lata J Vnitr Lek; 2003 Apr; 49(4):339-42. PubMed ID: 12793061 [TBL] [Abstract][Full Text] [Related]
30. [Hypertension therapy with beta blocker plus diuretic. "We are at the point of leaving behind an era"]. Dahlöf B MMW Fortschr Med; 2005 Mar; 147(12):8. PubMed ID: 15832781 [No Abstract] [Full Text] [Related]
33. The effect of drugs on the portal circulation. Reichen J; Lebrec D J Hepatol; 1987 Oct; 5(2):235-40. PubMed ID: 3320182 [No Abstract] [Full Text] [Related]
34. [Principal pharmacological properties of different beta-blockers, possibilities and new perspectives of their uses]. Antelava N; Antelava A; Pachkoria K; Pirtskhalaishvili N Georgian Med News; 2006 Dec; (141):38-46. PubMed ID: 17261885 [TBL] [Abstract][Full Text] [Related]
35. Benazepril plus amlodipine or hydrochlorothiazide for hypertension. Strauss MH; Weinstein J; Newton GE N Engl J Med; 2009 Mar; 360(11):1148; author reply 1149-50. PubMed ID: 19283888 [No Abstract] [Full Text] [Related]
36. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation. Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681 [TBL] [Abstract][Full Text] [Related]
37. Once spontaneous bacterial peritonitis develops, discontinue nonselective beta blockers permanently. A proposed practice change update. Tahan V Turk J Gastroenterol; 2014 Apr; 25(2):232. PubMed ID: 25003694 [No Abstract] [Full Text] [Related]
38. Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension. Reichen J Hepatology; 1990 Jun; 11(6):1066-78. PubMed ID: 2194921 [No Abstract] [Full Text] [Related]